1. When counseling patients who ask about a current case of onychomycosis, which patient misconception should be corrected by the pharmacist?

2. A man approaches the pharmacist stating, “I think I've got toenail fungus. My nail is white and flaky; it's breaking off on the end. That's always toenail fungus.” What is the best possible response?

3. New research indicates that recently introduced topical antifungals have superior cure rates compared with older topical antifungals. Which one of the following is a newer antifungal with a superior cure rate:

4. A patient has a history of cirrhosis subsequent to sustained alcohol abuse. Which one of the following antifungal medications is the best choice for him:

5. Which one of the following is a strong risk factor for onychomycosis:

6. A physician calls to inquire whether a woman taking warfarin 5 mg daily can use any oral antifungal medication for her onychomycosis. Which one of the following medications does not presently have an interaction with warfarin:

7. When speaking with patients about risk factors for onychomycosis, the pharmacist should advise them to

8. Research to develop new antifungals resulted in the discovery of medications that, when compared to older oral medications,

9. A pharmacist fills prescriptions for an woman for Nexium (esomeprazole) and Sporanox (itraconazole capsules). What type of counseling should be provided?

10. What adverse reactions should the pharmacist warn patients about when dispensing Kerydin (tavaborole)?

« Return to Activity